[31] A large study found that GLP-1 RA use was associated with lower risk of developing immune-mediated inflammatory diseases in patients with type 2 diabetes or obesity, suggesting a potential protective effect in some cohorts.[42] What the science is showing is potential for improvements: GLP-1RAs reduce blunt activation in fibroblast-like synoviocytes and improve joint inflammation and metabolic parameters in rheumatoid arthritis models and small human cohorts.[26][29][25] [31] Early clinical studies and case series in RA patients (especially those with coexisting type 2 diabetes or obesity) reported reduced disease activity scores (DAS28), lower C-reactive protein and erythrocyte sedimentation rate levels, fewer swollen joints, and diminished morning stiffness during GLP-1RA treatment, along with the expected weight reduction and improved insulin sensitivity.[31] Psoriasis showed improved PASI scores and quality-of-life metrics in patients with T2DM and psoriasis, alongside reductions in lesional skin and peripheral TNF-producing monocytes.[26] Case series show meaningful skin improvement.[26] In psoriasis and psoriatic arthritis , GLP-1RA therapy has been associated with improvements in inflammatory markers and disease severity indices

Once glucose enters the cell, blood sugar levels drop [1]
Key information on every label Total semaglutide content: Usually listed as a total milligram amount (e.g., "Semaglutide 5 mg")
If you are dealing with type 2 diabetes and finding it challenging to control your blood sugar levels despite making lifestyle adjustments and trying medications without success, incorporating GLP-1 Therapy into your treatment regimen could prove beneficial for you
These medications are tools, not shortcuts
Proper dosing and administration are crucial when using Ozempic, a once-weekly injectable diabetes drug for adults with type 2 diabetes